These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 28832951)
1. Comparative analysis of plant-produced, recombinant dimeric IgA against cell wall β-glucan of pathogenic fungi. Capodicasa C; Catellani M; Moscetti I; Bromuro C; Chiani P; Torosantucci A; Benvenuto E Biotechnol Bioeng; 2017 Dec; 114(12):2729-2738. PubMed ID: 28832951 [TBL] [Abstract][Full Text] [Related]
2. Plant production of anti-β-glucan antibodies for immunotherapy of fungal infections in humans. Capodicasa C; Chiani P; Bromuro C; De Bernardis F; Catellani M; Palma AS; Liu Y; Feizi T; Cassone A; Benvenuto E; Torosantucci A Plant Biotechnol J; 2011 Sep; 9(7):776-87. PubMed ID: 21265996 [TBL] [Abstract][Full Text] [Related]
3. Efficient generation of human IgA monoclonal antibodies. Lorin V; Mouquet H J Immunol Methods; 2015 Jul; 422():102-10. PubMed ID: 25910833 [TBL] [Abstract][Full Text] [Related]
4. Protection by anti-beta-glucan antibodies is associated with restricted beta-1,3 glucan binding specificity and inhibition of fungal growth and adherence. Torosantucci A; Chiani P; Bromuro C; De Bernardis F; Palma AS; Liu Y; Mignogna G; Maras B; Colone M; Stringaro A; Zamboni S; Feizi T; Cassone A PLoS One; 2009; 4(4):e5392. PubMed ID: 19399183 [TBL] [Abstract][Full Text] [Related]
5. [In vitro Antiviral Activity of Recombinant Antibodies of IgG and IgA Isotypes to Hemagglutinin of the Influenza A Virus]. Argentova VV; Aliev TK; Zarubaev VV; Klotchenko SA; Shtro AA; Sergeeva MV; Toporova VA; Dolgikh DA; Sveshnikov PG; Vasin VA; Kirpichnikov MP Mol Biol (Mosk); 2017; 51(6):927-937. PubMed ID: 29271957 [TBL] [Abstract][Full Text] [Related]
6. High polymeric IgA content facilitates recognition of microbial polysaccharide-natural serum antibody immune complexes by immobilized human galectin-1. Paul A; Antony M; Mathai J; Appukuttan PS Immunol Lett; 2011 Apr; 136(1):55-60. PubMed ID: 21147166 [TBL] [Abstract][Full Text] [Related]
7. Affinity purification of a framework 1 engineered mouse/human chimeric IgA2 antibody from tobacco. Boes A; Spiegel H; Delbrück H; Fischer R; Schillberg S; Sack M Biotechnol Bioeng; 2011 Dec; 108(12):2804-14. PubMed ID: 21755499 [TBL] [Abstract][Full Text] [Related]
8. Plant expression systems for early stage discovery and development of lead therapeutic antibodies. Virdi V; Juarez P; Depicker A Hum Antibodies; 2015 Dec; 23(3-4):37-43. PubMed ID: 27472860 [TBL] [Abstract][Full Text] [Related]
9. Psoriasin, a novel anti-Candida albicans adhesin. Brauner A; Alvendal C; Chromek M; Stopsack KH; Ehrström S; Schröder JM; Bohm-Starke N J Mol Med (Berl); 2018 Jun; 96(6):537-545. PubMed ID: 29736603 [TBL] [Abstract][Full Text] [Related]
10. Differences in N-glycan structures found on recombinant IgA1 and IgA2 produced in murine myeloma and CHO cell lines. Yoo EM; Yu LJ; Wims LA; Goldberg D; Morrison SL MAbs; 2010; 2(3):320-34. PubMed ID: 20431350 [TBL] [Abstract][Full Text] [Related]
11. Anti-beta-glucan antibodies in healthy human subjects. Chiani P; Bromuro C; Cassone A; Torosantucci A Vaccine; 2009 Jan; 27(4):513-9. PubMed ID: 19041357 [TBL] [Abstract][Full Text] [Related]
12. Deletion of the CaBIG1 gene reduces beta-1,6-glucan synthesis, filamentation, adhesion, and virulence in Candida albicans. Umeyama T; Kaneko A; Watanabe H; Hirai A; Uehara Y; Niimi M; Azuma M Infect Immun; 2006 Apr; 74(4):2373-81. PubMed ID: 16552067 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the titer and reactivity of antibody/ies against fungal cell wall β-glucans in human sera. Ishibashi K; Morita M; Motoi M; Liu Y; Miura NN; Adachi Y; Ohno N Int J Med Mushrooms; 2013; 15(2):115-26. PubMed ID: 23557364 [TBL] [Abstract][Full Text] [Related]
14. Recombinant dimeric IgA antibodies against the epidermal growth factor receptor mediate effective tumor cell killing. Lohse S; Derer S; Beyer T; Klausz K; Peipp M; Leusen JH; van de Winkel JG; Dechant M; Valerius T J Immunol; 2011 Mar; 186(6):3770-8. PubMed ID: 21317397 [TBL] [Abstract][Full Text] [Related]
15. Serum IgA subclasses and molecular forms in HIV infection: selective increases in monomer and apparent restriction of the antibody response to IgA1 antibodies mainly directed at env glycoproteins. Kozlowski PA; Jackson S AIDS Res Hum Retroviruses; 1992 Oct; 8(10):1773-80. PubMed ID: 1457191 [TBL] [Abstract][Full Text] [Related]
16. Decreased cytokine-induced IgA subclass production by CD40-ligated circulating B cells in primary IgA nephropathy. de Fijter JW; van Nisselrooij NI; Schroeijers WE; Daha MR; van Es LA; van Kooten C Nephrol Dial Transplant; 1998 Feb; 13(2):285-92. PubMed ID: 9509436 [TBL] [Abstract][Full Text] [Related]
17. Recombinant IgA production: single step affinity purification using camelid ligands and product characterization. Reinhart D; Weik R; Kunert R J Immunol Methods; 2012 Apr; 378(1-2):95-101. PubMed ID: 22570865 [TBL] [Abstract][Full Text] [Related]
18. In vitro regulation of IgA subclass synthesis. II. The source of IgA2 plasma cells. Conley ME; Bartelt MS J Immunol; 1984 Nov; 133(5):2312-6. PubMed ID: 6332844 [TBL] [Abstract][Full Text] [Related]
19. Antitumor immune effector mechanisms recruited by phage display-derived fully human IgG1 and IgA1 monoclonal antibodies. Huls G; Heijnen IA; Cuomo E; van der Linden J; Boel E; van de Winkel JG; Logtenberg T Cancer Res; 1999 Nov; 59(22):5778-84. PubMed ID: 10582699 [TBL] [Abstract][Full Text] [Related]
20. In vitro induction of the expression of multiple IgA isotype genes in rabbit B cells by TGF-beta and IL-2. Spieker-Polet H; Yam PC; Arbieva Z; Zhai SK; Knight KL J Immunol; 1999 May; 162(9):5380-8. PubMed ID: 10228015 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]